1. 2020
  2. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours

    Debie, P., Lafont, C., Defrise, M., Hansen, I., van Willigen, D. M., van Leeuwen, F. WB., Gijsbers, R., D'Huyvetter, M., Devoogdt, N., Lahoutte, T., Mollard, P. & Hernot, S., 10 Jan 2020, In : Journal of Controlled Release. 317, p. 34-42 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. 2019
  4. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

    Bolli, E., D'Huyvetter, M., Murgaski, A., Berus, D., Stangé, G., Clappaert, E. J., Arnouk, S., Pombo Antunes, A. R., Krasniqi, A., Lahoutte, T., Gonçalves, A., Vuylsteke, M., Raes, G., Devoogdt, N., Movahedi, K. & Van Ginderachter, J. A., 28 Nov 2019, In : Journal of Controlled Release. 314, p. 1-11 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., 10.7150/thno.34941.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  6. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 14 Oct 2019, In : Theranostics. p. 7772-7791 thno.34941.

    Research output: Contribution to journalSpecial issueResearch

  7. Influence of the degree of chelator conjugation on the physicochemical properties of Nanobody PET tracers

    Debie, P., Baudhuin, H., Puttemans, J., Hernot, S., Xavier, C. & Lahoutte, T., Oct 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S435-S435

    Research output: Contribution to journalMeeting abstract (Journal)Research

  8. Quantification of I-131 activity in mouse kidneys using micro-SPECT and ex vivo gamma counting: experimental evaluation of uncertainties

    Vargas, C. S., Struelens, L., D'Huyvetter, M., Eersels, J. L., Caveliers, V. & Covens, P., Oct 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S483-S483

    Research output: Contribution to journalMeeting abstract (Journal)Research

  9. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

    Lecocq, Q., Zeven, K., De Vlaeminck, Y., Martens, S., Massa, S., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 29 Sep 2019, In : Biomolecules. 9, 10, 20 p., 548.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Iodinated anti-HER2 sdAb effectively targets and treats HER2 positive brain lesions

    Puttemans, J., D'Huyvetter, M., Lahoutte, T. & Devoogdt, N., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  11. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

    Seremet, T., Jansen, Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P. & Neyns, B., 5 Sep 2019

    Research output: Other contributionResearch

Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 36386770